205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Negative revenue growth while NXPI stands at 1.45%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.86%
Negative EBIT growth while NXPI is at 0.98%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.38%
Negative operating income growth while NXPI is at 0.98%. Joel Greenblatt would press for urgent turnaround measures.
-0.12%
Negative net income growth while NXPI stands at 23.14%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.02%
Dividend growth of 13.02% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-8.03%
Negative OCF growth while NXPI is at 40.05%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-10.39%
Negative FCF growth while NXPI is at 43.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
70.78%
10Y revenue/share CAGR above 1.5x NXPI's 22.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
29.09%
5Y revenue/share CAGR 1.25-1.5x NXPI's 22.63%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
3.75%
3Y revenue/share CAGR under 50% of NXPI's 75.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR under 50% of NXPI's 2139.34%. Michael Burry would worry about a persistent underperformance in cash creation.
50.79%
Below 50% of NXPI's 2139.34%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
42.19%
3Y OCF/share CAGR under 50% of NXPI's 1835.78%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
177.33%
Net income/share CAGR 1.25-1.5x NXPI's 136.71%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
49.47%
Below 50% of NXPI's 136.71%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
200.49%
3Y net income/share CAGR similar to NXPI's 186.90%. Walter Schloss would attribute it to shared growth factors or demand patterns.
31.01%
Positive growth while NXPI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
26.82%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
2.97%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
1232.73%
Dividend/share CAGR of 1232.73% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
183.53%
Dividend/share CAGR of 183.53% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.21%
3Y dividend/share CAGR of 100.21% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-15.64%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.88%
Inventory growth well above NXPI's 0.94%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.99%
Negative asset growth while NXPI invests at 10.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.49%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-0.06%
We’re deleveraging while NXPI stands at 5.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.33%
Our R&D shrinks while NXPI invests at 1.02%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.34%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.